Related Experiment Video
Updated: Feb 14, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Blood clot parameters: Prejudgment of fibrinolysis in thromboelastography
Qiongyao Mou1, Qi Zhou1, Shengxiong Liu1
1Department of Biomedical Engineering, School of Pharmacy and Bioengineering, Digital Medical Instrument Laboratory, Chongqing University of Technology, Chongqing, PR China.
Background:
Thromboelastography (TEG) is a physical method to simulate the whole process of coagulation and fibrinolysis in the human body environment, and then it also can quickly determine whether patients with hypercoagulable, low coagulation, fibrinolysis or other symptoms. The first step in the diagnosis is based on two parameters: Estimated percentage of lysis (EPL) or the Lysis at 30 min (LY30). These two parameters are used to determine whether the sample has fibrinolysis. However, the determination of LY30 takes a long time, although EPL can reflect real-time fibrinolysis, sometimes the secondary fibrinolysis is not obvious.
Materials And Methods:
We have an extensive database of results from TEG of fibrinolysis and healthy whole blood (WB). These results were generated using citrated WB, followed by the addition of CaCl2, to initiate clot formation.
Results:
According to the characteristics of fibrinolysis, a new parameter clot retention time (CRT) was proposed to predict the status of fibrinolysis, and the normal range of the parameters was obtained in this paper.
Conclusion:
It is essential for the clinician to determine the fibrinolytic and ultimately contribute to the treatment of patients. We believe this parameter will add to the standardization of TEG parameters. The new parameter will also shorten the measurement time of non-fibrinolytic samples, which has definite physiological and pathological significance.
Related Concept Videos
Clot Retraction and Fibrinolysis
Wave Parameters
Distributions to Estimate Population Parameter
Dosage Regimens: Partial Pharmacokinetic Parameters
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Factors Influencing Drug Absorption: Anatomical Parameters

